Does angiotensin receptor blockade improve outcomes in patients with heart failure and preserved ejection fraction? Results of the I-PRESERVE study Henry Krum Clinical Trials Report 31 May 2009 Pages: 65 - 67
Nitric oxide regulation of autonomic function in heart failure Harold D. Schultz OriginalPaper 31 May 2009 Pages: 71 - 80
The brain renin-angiotensin-aldosterone system: A major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction Bing S. HuangFrans H. H. Leenen OriginalPaper 31 May 2009 Pages: 81 - 88
Insulin resistance and heart failure Patrick M. HeckDavid P. Dutka OriginalPaper 31 May 2009 Pages: 89 - 94
Respiratory muscle function and exercise intolerance in heart failure Jorge P. RibeiroGaspar R. ChiappaLutz Frankenstein OriginalPaper 31 May 2009 Pages: 95 - 101
Pharmacologic management of the cardiorenal syndrome in heart failure Henry KrumPupalan IyngkaranSuree Lekawanvijit OriginalPaper 31 May 2009 Pages: 105 - 111
Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: How much is too much? Bertram Pitt OriginalPaper 31 May 2009 Pages: 112 - 116
Should aldosterone blockade be used beyond current indications in heart failure? Marcelle D. SmitIsabelle C. van GelderDirk J. van Veldhuisen OriginalPaper 31 May 2009 Pages: 117 - 125
Pharmacologic management of patients with both heart failure and diabetes Michael R. MacDonaldMark C. PetrieJohn J. V. McMurray OriginalPaper 31 May 2009 Pages: 126 - 132